Vistin Pharma ASA (FRA:VP4)

Vistin Pharma ASA Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	84	78	89	92	67	86
Market Cap Growth	-5.67%	-12.78%	-3.07%	38.53%	-22.42%	16.22%
Enterprise Value	83	80	90	92	70	81
Last Close Price	1.81	1.72	2.07	1.80	1.44	1.67
PE Ratio	13.32	12.34	16.75	22.66	-	34.56
PS Ratio	2.20	2.04	2.45	2.36	2.30	3.08
PB Ratio	3.03	2.81	3.40	3.20	2.56	3.12
P/TBV Ratio	3.03	2.81	3.40	3.20	2.56	3.12
P/FCF Ratio	16.06	14.87	15.67	14.21	-	-
P/OCF Ratio	12.66	11.72	9.74	11.41	-	62.82
EV/Sales Ratio	2.05	2.08	2.45	2.36	2.43	2.90
EV/EBITDA Ratio	8.08	8.20	10.20	12.19	138.71	18.91
EV/EBIT Ratio	10.06	10.20	12.35	15.08	-	24.34
EV/FCF Ratio	15.79	15.18	15.71	14.23	-	-
Debt / Equity Ratio	0.01	0.01	0.00	-	0.18	0.01
Debt / EBITDA Ratio	0.01	0.01	0.01	-	7.95	0.03
Debt / FCF Ratio	0.02	0.02	0.02	-	-	-
Net Debt / Equity Ratio	-0.04	-0.04	-0.04	-0.08	0.18	-0.12
Net Debt / EBITDA Ratio	-0.13	-0.13	-0.11	-0.31	8.95	-0.80
Net Debt / FCF Ratio	-0.24	-0.24	-0.17	-0.36	-0.64	1.88
Asset Turnover	1.10	1.10	1.09	1.08	0.82	0.85
Inventory Turnover	1.91	1.91	1.91	2.16	2.19	2.57
Quick Ratio	1.54	1.54	1.01	1.24	0.62	1.92
Current Ratio	2.58	2.58	2.24	2.43	1.35	3.36
Return on Equity (ROE)	23.42%	23.42%	19.85%	15.29%	-1.72%	9.07%
Return on Assets (ROA)	14.00%	14.00%	13.53%	10.58%	-1.03%	6.35%
Return on Invested Capital (ROIC)	22.30%	23.54%	22.33%	17.30%	-2.17%	11.79%
Return on Capital Employed (ROCE)	25.60%	25.60%	26.60%	20.50%	-2.10%	11.40%
Earnings Yield	7.50%	8.11%	5.97%	4.41%	-0.67%	2.89%
FCF Yield	6.23%	6.73%	6.38%	7.03%	-10.68%	-2.13%
Dividend Yield	5.97%	7.37%	5.14%	4.96%	4.95%	4.48%
Payout Ratio	74.15%	74.15%	123.65%	-	-	89.17%
Total Shareholder Return	5.97%	7.37%	5.14%	4.96%	4.95%	4.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.